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Background: 25-hydroxyvitamin D (25[OH] Vit D) deficiency is known to be associated with coronary artery disease (CAD). It has been suggested 
that 25[OH] Vit D deficiency may be more prevalent among patients with acute coronary syndrome (ACS). Therefore, we evaluated 25[OH] Vit D 
levels among CAD patients with differing presentations.
Methods: Patients (N=2,910) diagnosed with CAD and with a 25[OH] Vit D level obtained at angiography were studied. 25[OH] Vit D was 
stratified into 3 categories (ng/mL): >30 (normal [N]; n=283), 16-30 (low [L]; n=2,270), and <15 (very low [VL]; n=357). Presentation (reason 
for angiography) was classified as stable angina, unstable angina (USA), and acute myocardial infarction (AMI). Associations between 25[OH] Vit D 
and major cardiovascular events (MACE; death, MI, CVA, or revascularization) stratified by presentation were made using multivariable Cox hazard 
regression.
Results: Patients averaged 65.2±11.6 years in age, 73.5% were male, and 90.3% had low 25[OH] Vit D (<30). Average follow-up was 6.0±4.4 
years. A total of 1072 (36.8%), 1175 (40.4%), and 663 (22.8%) presented with stable angina, USA, and AMI, respectively. Distribution of 25[OH] 
Vit D categories stratified by presentation (Stable angina: VL 38.1%, L 36.5%, N 37.8%; USA: VL 35.0%, L 40.7%, N 44.2%; AMI: VL 26.9%, L 22.7%, 
N 18.0%) showed no significant trend across categories of 25[OH] Vit D among differing presentations (p-trend=0.10). Mean 25[OH] Vit D levels 
across presentation categories were: stable angina: 24.4±7.9, USA: 24.5±7.9, and AMI: 23.6±7.7 (p-value=0.052). Among patients with stable 
angina, VL vs. N: HR=1.48, p=0.02 was predictive of MACE, but not for USA/MI patients (HR=1.06, p=0.64)
Conclusion: 25[OH] Vit D deficiency is prevalent among patients diagnosed with CAD regardless of their mode of presentation. However, it 
appears that severe 25[OH] Vit D deficiency in those with chronic (stable) coronary artery disease is most prevalent and best predicts risk of future 
cardiovascular events.
